EUVIMEDEUVIMED entdecken
Crossref

Cytomegalovirus Infection After CD‐34 Selected Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis

Brennan Collis iD, Tanya Helms, Gwynn D Long, Patrick C K Tam iD

Transplant Infectious Disease · 2026

DOI: 10.1111/tid.70144 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant Infectious Disease, 2026. Verfasst von Brennan Collis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA. Hauptthemen laut MEDLINE: Cytomegalovirus Infections, Hematopoietic Stem Cell Transplantation, Scleroderma, Systemic. Die Arbeit nennt 30 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Autologous hematopoietic stem cell transplantation (AHSCT) is increasingly used to treat systemic sclerosis (SSc). Data on post‐AHSCT infections, including cytomegalovirus (CMV) in this population, are limited. This study aimed to assess risk factors, infection rates, and outcomes of post‐transplant CMV infection following CD34‐selected AHSCT for SSc.

Methods

We performed a single‐center retrospective study of all AHSCT recipients for SSc complicated by CMV infection. A standardized pre‐emptive CMV monitoring approach was employed throughout the study period (antiviral treatment threshold: plasma VL > 450 IU/mL). The primary outcome was the rate of CMV DNAemia or disease. Secondary outcomes included risk factors, management, and treatment outcomes.

Results

Among 42 AHSCT recipients, 19 (45%) were CMV‐seropositive pre‐transplant. CMV DNAemia occurred in 10/42 (24%) recipients post‐transplant, of which 8/10 (80%) were CMV‐seropositive. Median time to CMV DNAemia was 28 days (range: 21–35) post‐transplant, with a median peak VL of 665 IU/mL (IQR: 340–1104). There were no cases of CMV disease. CMV seropositivity pre‐transplant was a significant predictor of post‐transplant CMV DNAemia (relative risk: 4.84, 95% CI: 1.16–20.14; p = 0.026). Of 10 patients with CMV DNAemia, six (60%) received CMV‐targeted therapy while four (40%) resolved without treatment. Median duration of CMV targeted therapy was 35 days (IQR: 29–45). One patient (10%) experienced gastrointestinal intolerance necessitating antiviral discontinuation. No patient died or required hospitalization due to CMV infection.

Conclusions

CMV DNAemia following CD34‐selected AHSCT occurred primarily in CMV‐seropositive recipients. Though common, CMV DNAemia occurred early post‐transplant and was associated with minimal morbidity.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytomegalovirus InfectionsHematopoietic Stem Cell TransplantationScleroderma, SystemicHumansRetrospective StudiesFemaleMaleMiddle AgedTransplantation, AutologousCytomegalovirusAdultRisk FactorsAntigens, CD34Antiviral AgentsAgedDNA, ViralTreatment Outcome

Stichwörter der Autor:innen

autoimmune diseasecytomegalovirushematopoietic stem cell transplantation

Substanzen

Antigens, CD34Antiviral AgentsDNA, Viral

Autor:innen und Institutionen

  • Department of Medicine, Division of Infectious Diseases, Duke University School of Medicine, Durham, North Carolina, USA.
  • Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, North Carolina, USA.
  • College of Medicine and Public Health, Flinders University, Adelaide, Australia.

ORCID-Profile: Brennan Collis, Patrick C K Tam

Zitieren

APA

Collis, B., Helms, T., Long, G. D., & Tam, P. C. K. (2026). Cytomegalovirus Infection After CD‐34 Selected Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis. Transplant Infectious Disease. https://doi.org/10.1111/tid.70144

Vancouver

Collis B, Helms T, Long GD, Tam PCK. Cytomegalovirus Infection After CD‐34 Selected Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis. Transplant Infectious Disease. 2026. doi:10.1111/tid.70144

BibTeX
@article{Collis2026,
  author = {Collis, Brennan and Helms, Tanya and Long, Gwynn D and Tam, Patrick C K},
  title = {Cytomegalovirus Infection After CD‐34 Selected Autologous Hematopoietic Stem Cell Transplantation for Systemic Sclerosis},
  journal = {Transplant Infectious Disease},
  year = {2026},
  doi = {10.1111/tid.70144}
}
Kostenlos starten →